StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Bio Essence's operating cash flow for the twelve months ending Sep 30, 2026 was $519.88K, down 30.8% year over year. For fiscal 2025 it was $1.57M, up 151.6% from the year before. The highest annual figure on record is $1.57M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.57M+151.6%
FY2024Dec 31, 2024$623.87K–
FY2023Dec 31, 2023-$1.03M–
FY2022Dec 31, 2022-$703.24K–
FY2021Dec 31, 2021-$1.29M–
FY2020Dec 31, 2020-$732.74K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$368.85K-297.3%
Q2 FY2026Jun 30, 2026$59.65K-64.5%
Q1 FY2026Mar 31, 2026-$411.97K–
Q4 FY2025Dec 31, 2025$1.24M+193.3%
Q3 FY2025Sep 30, 2025$186.97K-47.6%
Q2 FY2025Jun 30, 2025$167.80K+998.7%
Q1 FY2025Mar 31, 2025-$26.07K–
Q4 FY2024Dec 31, 2024$423.07K–
Q3 FY2024Sep 30, 2024$357.14K–
Q2 FY2024Jun 30, 2024$15.27K–
Q1 FY2024Mar 31, 2024-$171.61K–
Q4 FY2023Dec 31, 2023-$204.09K–
Q3 FY2023Sep 30, 2023-$344.85K–
Q2 FY2023Jun 30, 2023-$245.01K–
Q1 FY2023Mar 31, 2023-$231.72K–
Q4 FY2022Dec 31, 2022-$129.28K–
Q3 FY2022Sep 30, 2022-$130.28K–
Q2 FY2022Jun 30, 2022-$189.21K–
Q1 FY2022Mar 31, 2022-$254.48K–
Q4 FY2021Dec 31, 2021-$142.57K–
Q3 FY2021Sep 30, 2021-$173.12K–
Q2 FY2021Jun 30, 2021-$819.79K–
Q1 FY2021Mar 31, 2021-$158.64K–
Q4 FY2020Dec 31, 2020-$236.73K–
Q3 FY2020Sep 30, 2020-$210.00K–
Q2 FY2020Jun 30, 2020-$227.54K–
Q1 FY2020Mar 31, 2020-$58.48K–

More Bio Essence figures

See a number that looks wrong?